Myriad(US:MYGN) Xin Lang Cai Jing·2026-02-19 19:54Group 1 - The core viewpoint of the article highlights the frequent changes in beneficial ownership disclosures for Myriad Genetics (MYGN.US), indicating active involvement from institutional investors [1][3] Group 2 - On February 10, 2026, State Street Corporation reported acquiring a 6.4% beneficial ownership, totaling 5,966,567 shares, effective as of December 31, 2025 [2] - Glenview Capital Management disclosed holding approximately 5.30% of shares, equating to 4,941,058 shares on the same date [2] - The company submitted multiple SCHEDULE 13G regulatory filings on February 4, 9, and 12, 2026, updating the changes in shareholding [2] Group 3 - On January 12, 2026, Myriad Genetics released an 8-K report concerning operational matters, which, along with the ownership statements from February 2026, indicates heightened activity from institutional investors that may influence market sentiment [3]